Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of British Columbia

$25,000.00

Concise synthesis of a sensor for Cyclophosphamide

FY 2011-12

Summary
A recent study shows that people working in BC hospitals are exposed to chemotherapeutics, even those who did not handle the drugs. The drugs are absorbed through dermal contact, ingestion and/or inhalation. Given that the intent of these drugs is to kill cells, this exposure is a major problem for health-industry workers. Unfortunately, to date, no standard protocol has been developed measure the amount of exposure for health care workers. Cyclophosphamide is a specific example of a chemotherapeutic contaminant in BC hospitals. This drug is used to treat a variety of cancers, including various lymphomas. Cyclophosphamide functions as an alkylating agent, rendering it cytotoxic (i.e., it kills cells). Although killing of cancer cells is obviously desirable, healthy cells are not immune. This leads to considerable side effects, which are worth tolerating if you are a cancer patient, but unacceptable for those who just happen to be working in an environment where cytotoxic drugs are administered. Of particular concern is that cyclophosphamide itself can cause certain types of cancer. As a result, it is highly desirable to be able to detect exposure to this drug and then eradicate the contaminant. Nanozen is working on the development of an effective air monitoring dosimeter to detect cyclophosphamide. This requires the availability of a suitable small molecule sensor. Nanozen does not have the expertise to synthesize such a compound and therefore wants to collaborate with Prof. Jennifer Love. Thus, the objective of this proposal is to develop an efficient, scalable synthetic route to the small molecule sensor.
Program
Engage Grants Program
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
428368-2011
Name nom
Love, Jennifer
Department département
Chemistry
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
25000
Program id
EGP
Program nane en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
500
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Manufacturing processes and products
Area of application fr
Procédés et produits industriels
Research subject code
3703
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic syntheses
Research subject fr
Synthèses organiques
Partie
1
Nb partie
1
Application title
Concise synthesis of a sensor for Cyclophosphamide
Keyword
NSERC
Application summary
A recent study shows that people working in BC hospitals are exposed to chemotherapeutics, even those who did not handle the drugs. The drugs are absorbed through dermal contact, ingestion and/or inhalation. Given that the intent of these drugs is to kill cells, this exposure is a major problem for health-industry workers. Unfortunately, to date, no standard protocol has been developed measure the amount of exposure for health care workers. Cyclophosphamide is a specific example of a chemotherapeutic contaminant in BC hospitals. This drug is used to treat a variety of cancers, including various lymphomas. Cyclophosphamide functions as an alkylating agent, rendering it cytotoxic (i.e., it kills cells). Although killing of cancer cells is obviously desirable, healthy cells are not immune. This leads to considerable side effects, which are worth tolerating if you are a cancer patient, but unacceptable for those who just happen to be working in an environment where cytotoxic drugs are administered. Of particular concern is that cyclophosphamide itself can cause certain types of cancer. As a result, it is highly desirable to be able to detect exposure to this drug and then eradicate the contaminant. Nanozen is working on the development of an effective air monitoring dosimeter to detect cyclophosphamide. This requires the availability of a suitable small molecule sensor. Nanozen does not have the expertise to synthesize such a compound and therefore wants to collaborate with Prof. Jennifer Love. Thus, the objective of this proposal is to develop an efficient, scalable synthetic route to the small molecule sensor.